EUDA, EUDAW · CIK 0001847846 · operating
EUDA Health Holdings Limited is a healthcare services provider incorporated in the British Virgin Islands and headquartered in Singapore. The company operates primarily across Singapore, Malaysia, and China, offering non-invasive treatment services and related products. Its service offerings include bioenergy capsule therapy, stem cell therapy, and CRISPR gene editing treatments, along with a line of health supplements. The company also maintains a property management business segment.
The company operates with approximately 117 full-time employees and maintains a presence across multiple Asian markets. Beyond its core healthcare services, EUDA generates revenue through its property management operations. The company is publicly listed on Nasdaq, providing liquidity for its equity securities.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2022 | — | $-2.07 | — |